PATEL SANJIV (President and CEO) sold 7.0% of their position (61.42K shares) of RELAY THERAPEUTICS, INC. on the open market
Open‑market sale worth $182.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/24/2025ACC: 0000950170-25-057996
DirectorOfficer· President and CEO
Since Jul 2020
-61.42K
Net shares
Net seller
$182.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
61.42K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−42.77K
Price / share
$2.97
Trade value
$127.02K
% of position
4.8%
4/23/2025
883.09K→840.32K
Common Stock
Direct
Shares
−18.65K
Price / share
$2.97
Trade value
$55.40K
% of position
2.2%
4/23/2025
840.32K→821.67K
Total
Net shares
−61.42K
Net value
-$182.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/23/2025 | S · Sale | −42.77K | $2.97 | $127.02K | 4.8% | 883.09K | 840.32K |
| Common Stock Direct | 4/23/2025 | S · Sale | −18.65K | $2.97 | $55.40K | 2.2% | 840.32K | 821.67K |
| Total | −61.42K | -$182.42K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned687.36K
Common Stock
IndirectShares owned199.55K
Total
886.90K indirect886.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 687.36K | Indirect |
| Common Stock | 199.55K | Indirect |
| Total | 886.90K | 886.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported